Vanda Pharmaceuticals
VNDA
VNDA
151 hedge funds and large institutions have $206M invested in Vanda Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 47 increasing their positions, 52 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
151
Holders Change
+3
Holders Change %
+2.03%
% of All Funds
2.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
47
Reduced
52
Closed
21
Calls
$1.57M
Puts
$261K
Net Calls
+$1.31M
Net Calls Change
+$2.12M
Top Buyers
| 1 |
1
BlackRock
New York
|
$40.3M |
| 2 |
2
Goldman Sachs
New York
|
$3.57M |
| 3 |
3
Millennium Management
New York
|
$1.87M |
| 4 |
4
Dimensional Fund Advisors
Austin,
Texas
|
$10.6M |
| 5 |
TCM
5
Tang Capital Management
San Diego,
California
|
$11M |
